Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Bardenheuer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 20, 2018
[Treatment-Refractory Pain]Jens Keßler, Marcus Geist, Hubert Bardenheuer
Palliative Medicine|April 27, 2019
Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3AMarcus Geist, Hubert Bardenheuer, Juergen Burhenne, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 16, 2004
Endovascular aortic arch reconstruction with supra-aortic transposition for symptomatic contained rupture and dissection: early experience in 8 high-risk patientsHardy Schumacher, Dittmar Böckler, Hubert Bardenheuer, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapiesMarcus J P Geist, Nelly Siller, Gerlinde Egerer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trialKonrad Streitberger, Mireen Friedrich-Rust, Hubert Bardenheuer, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|June 4, 2008
INNOMOTION for percutaneous image-guided interventions: principles and evaluation of this MR- and CT-compatible robotic systemAndreas Melzer, Bernd Gutmann, Thomas Remmele, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 17, 2015
Education in End-of-Life Care: What Do Experienced Professionals Find Important?Karin Jors, Katharina Seibel, Hubert Bardenheuer, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 29, 2006
Complications after endovascular repair of acute symptomatic and chronic expanding Stanford type B aortic dissectionsDittmar Böckler, Hardy Schumacher, Marika Ganten, et al.
Cancer|September 10, 2014
Dying in cancer centers: do the circumstances allow for a dignified death?Karin Jors, Sandra Adami, Carola Xander, et al.
Critical Care (London, England)|October 14, 2008
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigationNalan Kayhan, Benjamin Funke, Lars Oliver Conzelmann, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|September 20, 2018
[Treatment-Refractory Pain]Jens Keßler, Marcus Geist, Hubert Bardenheuer
Palliative Medicine|April 27, 2019
Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3AMarcus Geist, Hubert Bardenheuer, Juergen Burhenne, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 16, 2004
Endovascular aortic arch reconstruction with supra-aortic transposition for symptomatic contained rupture and dissection: early experience in 8 high-risk patientsHardy Schumacher, Dittmar Böckler, Hubert Bardenheuer, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapiesMarcus J P Geist, Nelly Siller, Gerlinde Egerer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trialKonrad Streitberger, Mireen Friedrich-Rust, Hubert Bardenheuer, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|June 4, 2008
INNOMOTION for percutaneous image-guided interventions: principles and evaluation of this MR- and CT-compatible robotic systemAndreas Melzer, Bernd Gutmann, Thomas Remmele, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 17, 2015
Education in End-of-Life Care: What Do Experienced Professionals Find Important?Karin Jors, Katharina Seibel, Hubert Bardenheuer, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 29, 2006
Complications after endovascular repair of acute symptomatic and chronic expanding Stanford type B aortic dissectionsDittmar Böckler, Hardy Schumacher, Marika Ganten, et al.
Cancer|September 10, 2014
Dying in cancer centers: do the circumstances allow for a dignified death?Karin Jors, Sandra Adami, Carola Xander, et al.
Critical Care (London, England)|October 14, 2008
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigationNalan Kayhan, Benjamin Funke, Lars Oliver Conzelmann, et al.
Pageof 2